Medivir presents mature clinical data for fostrox + Lenvima in liver cancer (HCC) at the European Society for Medical Oncology (ESMO) Congress, Barcelona on Sep 16th 2024.
Follow a live broadcast presentation and interview afterward from Barcelona, allowing participants to send in questions beforehand.
Dr. Hong Jae Chon, CHA Bundang Hospital, Seoul, Korea
Fostrox + Lenvatinib moving forward.
Dr Pia Baumann, Chief Medical Officer, Medivir AB